|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A01N 55/08 | |
| A61K 31/69 | |||
| A61P 31/12 |
| (11) | Number of the document | 2744342 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12824599.0 |
| Date of filing the European patent application | 2012-08-17 | |
| (97) | Date of publication of the European application | 2014-06-25 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/051349 |
| Date | 2012-08-17 |
| (87) | Number | WO 2013/025992 |
| Date | 2013-02-21 |
| (30) | Number | Date | Country code |
| 201161524429 P | 2011-08-17 | US | |
| 201161526787 P | 2011-08-24 | US |
| (72) |
WALKER, Jill, US
VOITENLEITNER, Christian, US
PEAT, Andy, US
SHOTWELL, Brad, US
|
| (73) |
GlaxoSmithKline LLC,
251 Little Falls Drive, Wilmington, DE 19808,
US
|
| (54) | THERAPEUTIC METHODS |
| THERAPEUTIC METHODS |